Citations

Clear

426 citation(s) found for "ST, Reza".

Glucagon-like Peptide-1 Receptor Agonists in Liver Transplant Recipients: A Retrospective Cohort Study
Sheashaa, Hesham, Ibrahim, Ramzi, Elshaer, Amani , Mouhaffel, Rama, Habib, E., Abdelnabi, Mahmoud, Farina, Juan M., Lester, Steven J., Simper, David, Steidley, Eric, Aqel, B., Barnhill, Michele , Kim, W. Ray, Ayoub, Chadi, Arsanjani, Reza, Ibrahim, Ramzi , Ibrahim, Ramzi , Steidley, Eric D, Pham, Hoang Nhat , Abdelnabi, Mahmoud , Farina, Juan M., Alsidawi, Said , Aqel, Bashar A. , Arsanjani, Reza

Mayo Clinic

Transplantation Direct | March 23, 2026 | Volume: 12 | Issue: 4 | Pages: e1932

10.1097/txd.0000000000001932 | PMID 41884702 Get It

Background. Liver transplant recipients face high risks of cardiometabolic events after transplant, driven by posttransplant weight gain, diabetes, hypertension, as well as immunosuppression-related side effects. Glucagon-like peptide-1 receptor agonists (GLP1RAs) improve metabolic and cardiorenal outcomes in nontransplant populations, but their role in liver transplant recipients remains understudied. Methods. This retrospective cohort study used TriNetX data (January 2010–December 2023) to compare outcomes in liver transplant recipients prescribed GLP1RAs (semaglutide, dulaglutide, liraglutide) within 1-mo posttransplant (n = 546) versus nonusers (n = 37 153). Propensity score matching (1:1) balanced demographics, comorbidities, and medications (n = 541 per group). Outcomes included mortality, hospitalizations, cardiovascular/renal/respiratory events, and graft outcomes. Results. Over a mean follow-up 838.5 d (SD 291.9) in the GLP1RA cohort and 884.3 d (SD 313.7) in the non-GLP1RA group, GLP1RA use was associated with a 43% lower all-cause mortality (7.0% versus 12.9%; hazard ratio [HR], 0.566; 95% confidence interval [CI], 0.381-0.841) and 39% fewer hospitalizations (60.4% versus 74.5%; HR, 0.613; 95% CI, 0.530-0.710). Acute heart failure (HR, 0.386; 95% CI, 0.285-0.524), renal failure/dialysis (HR, 0.489; 95% CI, 0.413-0.579), and respiratory failure (HR, 0.484; 95% CI, 354-0.662) risks were significantly reduced. No differences were observed in graft failure/rejection, myocardial infarction, stroke, atrial fibrillation/flutter, ventricular tachycardia, or ischemic optic neuropathy. Conclusions. Early GLP1RA initiation in liver transplant recipients was associated with reduced mortality, hospitalizations, respiratory, and cardiorenal complications without compromising graft safety. These findings support GLP1RAs as a promising adjunct therapy, warranting prospective trials to confirm benefits in this high-risk population.
Reporting a Novel Disease Causing Variant in PGAP3 Associated With Hyperphosphatasia and Intellectual Disability: A Case Report and Comprehensive Literature Review
Salmaninejad, Arash , Seyedtaghia, Mohammad Reza , Bereshneh, Ali Hosseini , Azizi, Nasrin , Bayat, Reza , Esnaashari, Somaye , Aminzadeh, Vahid , Koohmanaee, Shahin , Savad, Shahram , Mojarrad, Majid , Dalili, Setila , Dalili, Setila

Mayo Clinic

Molecular Genetics & Genomic Medicine | March 23, 2026 | Volume: 14 | Issue: 3 | Pages: No page available

10.1002/mgg3.70206 | PMID 41866703 Get It

ABSTRACT Background A rare autosomal recessive disorder known as hyperphosphatasia with impaired intellectual development syndrome (HPMRS), also referred to as Mabry syndrome, is caused by a deficiency in glycosylphosphatidylinositol (GPI). Elevated blood alkaline phosphatase (ALP) levels, cognitive impairment, and epileptic seizures are among its key features. These pathways are involved in the synthesis of GPI and the transfer of GPI anchor to the proteins, fatty acid remodeling, and transport of GPI‐anchored proteins (GPI‐APs). Methods Using exome sequencing (ES), the cause of hyperphosphatasia and ID of an 11‐year‐old girl from non‐consanguineous parents was solved, and the results confirmed by direct Sanger sequencing method. Results ES identified a novel homozygous pathogenic variant, PGAP3 (NM_033419.5: c.202dupT, p.Cys68fs*2) that segregated within the family members. To the best of our knowledge at the time of writing this manuscript, this variant has not been reported in HPMRS in the literature. Conclusion Our findings indicate that the p.Cys68fs*2 variant may disrupt normal protein function and likely disrupt its interaction with its associated partner proteins, potentially leading to disruption of GPI biosynthesis. We present a novel pathogenic variant thus expanding the phenotypic and mutational spectrum of this extremely rare disorder. Elevated ALP assays and ES are valuable diagnostic tools for HPMRS. Additionally, a comprehensive literature review was conducted to expand the phenotypic and genotypic spectrum within the PGAP3 gene responsible for HPMRS.
EchoAtlas: A Conversational, Multi-View Vision-Language Foundation Model for Echocardiography Interpretation and Clinical Reasoning
Chao, Chieh-Ju, Asadi, Mohammad, Ramasamy, Gokul , Pecco, Nicolò , Oh, Jae K. , Banerjee, Imon, Langlotz, Curtis P, Fei-Fei, Li , Adeli, Ehsan, Erickson, B., Chao, Chieh‐Ju , Chao, Chieh-Ju , Wang, Yu-Chiang , Poterucha, Timothy, Kane, Garvan, Fei-Fei, Li , Erickson, Bradley J , Asadi, Mohammad, Li, Lavonda, Poterucha, Timothy Joseph , Arsanjani, Reza , Kane, Garvan C. , Banerjee, Imon , Langlotz, Curtis P. , Adeli, Ehsan

Mayo Clinic

No container title available | March 18, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.03.14.26348388 | PMID 41891021 Get It

Abstract Echocardiography is the most widely used cardiac imaging modality, yet artificial intelligence-enabled interpretation remains limited by the inability of existing models to integrate visual assessment, quantitative measurement, and clinical reasoning within a unified framework. Here we present EchoAtlas, the first autoregressive vision-language model developed for echocardiographic interpretation. Trained on over 12.9 million question-answer pairs derived from approximately 2 million echocardiogram videos, EchoAtlas achieves 0.966 accuracy on multiple-choice questions in our internal test set and establishes a new state-of-the-art on the public MIMIC-EchoQA benchmark (0.699 vs. 0.508 previously). EchoAtlas also provides accurate quantitative measurements, segment-level regional wall motion assessment, longitudinal comparison, and diagnostic reasoning across diverse question formats — capabilities not previously demonstrated in this domain. These results highlight the potential of autoregressive vision-language models as a foundation for interactive echocardiographic interpretation, representing an early step toward scalable, auditable artificial intelligence systems in cardiology practice.
Impact of Mavacamten Approval on Septal Reduction Therapy Rates in Hypertrophic Cardiomyopathy
Ibrahim, Ramzi, Wang, Winston , Pham, Hoang Nhat, Abdelnabi, Mahmoud, Lester, Steven J., Wilansky, Susan , Schaff, Hartzell V. , Geske, Jeffrey B., Arsanjani, Reza, Ayoub, Chadi , Geske, Jeffrey B. , Arsanjani, Reza , Ibrahim, Ramzi , Pham, Hoang Nhat , Ibrahim, Ramzi , Nhat, Hoang , Abdelnabi, Mahmoud , Geske, Jeffrey B , Arsanjani, Reza , Schaff, Hartzell

Mayo Clinic

Journal of the American Heart Association | March 4, 2026 | Volume: 15 | Issue: 6 | Pages: No page available

10.1161/jaha.125.045649 | PMID 41778598 Get It

Diagnosis and Treatment of Nontraumatic Osteonecrosis of the Femoral Head: A Systematic Review and Meta-Analyses for the ARCO Clinical Practice Guideline Development Workgroup
Parikh, Romil, Mirzaei, Alireza, Butler, Mary E., Restrepo, Diego J. , Perez, Sergio F. Guarin , Brandt, Sallee , Swartz, Gabrielle, Katanbaf, Reza , Goodman, Stuart B. , Mont, M. Isabel Matilla, CUI, QUANJUN , Jones, Lynne C. , Cheng, Edward Y., Goodman, Stuart B. , Restrepo, Diego J. , Parikh, Romil R , Guarin Perez, Sergio F , Mirzaei, Alireza , Swartz, Gabrielle N , Mont, Michael A.

Mayo Clinic

Medical Sciences | February 23, 2026 | Volume: 14 | Issue: 1 | Pages: 107

10.3390/medsci14010107 | PMID 41892822 Get It

Background/Objectives: Diagnostic evaluation and management of nontraumatic osteonecrosis of the femoral head (ONFH) vary substantially. This systematic review was conducted to inform development of the Association Research Circulation Osseous (ARCO) clinical practice guideline for diagnosis and treatment of ARCO stages I to III ONFH. Methods: We searched MEDLINE, EMBASE, Web of Science, SCOPUS, Global Index Medicus, and the Cochrane Library for studies evaluating imaging modalities and treatments for adult ONFH. We assessed risk of bias using the QUADAS-2, the ROB-2, and the ROBINS-I tools; conducted meta-analyses using random-effects regression; and evaluated certainty of evidence using GRADE methodology. Results: Among 36 included studies, 18 addressed diagnostic test accuracy and 18 addressed comparative effectiveness of treatments. Magnetic resonance imaging (MRI) demonstrated the highest pooled sensitivity (0.91; 95% confidence interval (CI), 0.87 to 0.94) and specificity (0.96; 95% CI, 0.87 to 0.99) for ONFH diagnosis. Bone marrow edema and grade 2+ joint effusion on MRI differentiated symptomatic versus asymptomatic disease. Computed tomography and MRI better detected subchondral fractures than plain radiography. Very low-grade evidence suggested lower rates of femoral head collapse with core decompression plus bone marrow concentrate compared with core decompression alone (pooled relative risk [RR], 0.55; 95% CI, 0.36 to 0.83), and with vascularized versus non-vascularized bone grafting (RR, 0.35; 95% CI, 0.14 to 0.84) over a ≤5-year follow-up. Based on three non-comparative case series, osteotomies might have a lower risk of collapse over a 10- to 20-year follow-up, but this needs to be evaluated in future comparative research. Inconsistent outcome reporting hindered treatment outcome pooling. There were no comparative studies that evaluated observation only versus intervention in asymptomatic disease or strategies for monitoring treatment response. Conclusions: Evidence supporting optimal imaging modalities and early joint-preserving interventions remains limited and predominantly observational, underscoring the need for high-quality comparative studies with consistently defined core outcomes to guide clinical decision-making.
Pericardial Effusion and Bruton Tyrosine Kinase Inhibitors in B-Cell Malignant Disease
Zanco, Julia , Ibrahim, Ramzi, Pham, Hoang Nhat, Farina, Juan M., Narayanasamy, Hema, Tamarappoo, Balaji , Herrmann, Joerg, Ayoub, Chadi, Arsanjani, Reza, Larsen, Carolyn M , Ibrahim, Ramzi , Pham, Hoang Nhat , Farina, Juan M., Larsen, Carolyn , Herrmann, Joerg , Arsanjani, Reza

Mayo Clinic

JAMA Oncology | February 19, 2026 | Volume: 12 | Issue: 4 | Pages: 419

10.1001/jamaoncol.2025.6605 | PMID 41712203 Get It

This cohort study examines the association of bruton tyrosine kinase inhibitor therapy in B-cell malignant disease with increased risk of pericardial effusion and cardiovascular outcomes.
Prognostic Significance of Prolonged QTc Interval in Patients on Dialysis: A Retrospective Cohort Study
Pham, Hoang Nhat, Ibrahim, R, Giauque, Nathan A., Mahmoud, Ahmed K., Dreher, Luke, Scott, Luis R., Ayoub, Chadi, Arsanjani, Reza, LeMond, Lisa , Singh, Amitoj, Sorajja, Dan , Ayoub, Chadi , Ayoub, Chadi , Pham, Hoang Nhat , Giauque, Nathan Anthony, Mahmoud, Ahmed K , Dreher, Luke , Scott, Luis R. , Arsanjani, Reza , Singh, Amitoj

Mayo Clinic

Journal of Arrhythmia | February 19, 2026 | Volume: 42 | Issue: 1 | Pages: No page available

10.1002/joa3.70299 | PMID 41727701 Get It

ABSTRACT Background Prolonged QT interval is common in end‐stage renal disease (ESRD) on dialysis, but its long‐term cardiovascular (CV) implications remain unclear. Methods Using TriNetX network (2010–2024), we identified adults with ESRD on dialysis and categorized them by QTc status. After 1:1 propensity score matching ( n = 3428/group), outcomes (hazard ratio [HR]) were assessed using Cox regression. Results Prolonged QTc (> 500 ms) was associated with higher risk of all‐cause mortality (HR 1.67; p < 0.001), MACEs (HR 1.40; p < 0.001), cardiac arrest (HR 1.75; p < 0.001), sustained ventricular arrhythmia (HR 1.66; p < 0.001), new‐onset atrial fibrillation (HR 1.12; p = 0.01), and acute myocardial infarction (HR 2.19; p < 0.001). Conclusions In ESRD patients on dialysis, prolonged QT interval was independently associated with adverse CV outcomes and mortality.
AhR activation inhibits DRP1-induced mitochondrial fission in airway smooth muscle during asthma
Tandberg, Cheyenne, Kumar, Ashish, Balraj, Premanand , Thompson, Michael A, Prakash, Y S, Pabelick, Christina M, Britt, Rodney D. , Kumar, Ashish , Reza, Mohammad Irshad , Pabelick, Christina M. , Sathish, Venkatachalem

Mayo Clinic

American Journal of Respiratory Cell and Molecular Biology | February 10, 2026 | Volume: 74 | Issue: 7 | Pages: 858-868

10.1093/ajrcmb/aanag019 | PMID 41738274 Get It

Abstract In asthma, pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNFα) drive excessive mitochondrial fission in ASM cells through activating dynamin-related protein 1 (DRP1). Recently, we demonstrated that aryl hydrocarbon receptor (AhR) is expressed in human ASM and is upregulated during inflammation and asthma. This study explores the role of AhR in regulating mitochondrial fission in human ASM cells under pro-inflammatory and asthmatic conditions. Primary human nonasthmatic and asthmatic ASM cells were treated with 6-formylindolo[3,2-b]carbazole (FICZ: AhR agonist), with or without TNFα. Mitochondrial morphology was assessed using MitoTracker staining. DRP1 expression was evaluated in whole-cell and mitochondrial fractions. Loss- and gain-of-function studies (AhR inhibition, knockdown, and overexpression) were performed. AhR binding on the DRP1 promoter and promoter activity were assessed by ChIP-qPCR and luciferase reporter. The effects of AhR activation on oxygen consumption rate (OCR) were analyzed using seahorse XF-Pro. AhR activation significantly inhibited TNFα- and asthma-induced mitochondrial fission in ASM cells via inhibiting DRP1 in both inactive and active forms. In contrast, AhR inhibition or knockdown aggravated mitochondrial fission, while AhR overexpression failed to prevent TNFα-induced fission without ligand activation. Mechanistically, AhR bound the DRP1 promoter and suppressed its promoter activity, consistent with a genomic mode of action, while failing to alter ERK1/2 phosphorylation. Additionally, AhR activation also reduced TNFα- and asthma-induced increase in OCR. Collectively, this study shows that AhR activation prevents mitochondrial fission by inhibiting DRP1 in ASM during inflammation and highlights AhR as a promising therapeutic target for asthma and other airway diseases associated with mitochondrial dysfunction.
Artificial intelligence–based quantification of breast arterial calcifications to predict cardiovascular morbidity and mortality
Dapamede, Theo , Khan, Aisha Urooj , Joshi, Vedant , Gershon, Gabrielle , Li, Frank , Chavoshi, Mohammadreza , Brown-Mulry, Beatrice , Isaac, Rohan , Mansuri, Aawez , Robichaux, Chad , Sperling, Laurence , O’Neill, W Charles , Dapamede, Theodorus , Urooj, Aisha , Isaac, Rohan Satya , Ayoub, Chadi , Arsanjani, Reza , Sperling, Laurence , Gichoya, Judy W. , van Assen, Marly , O'Neill, W Charles , Banerjee, Imon , Trivedi, Hari , Arsanjani, Reza , Gichoya, Judy Wawira , Assen, Marly van , Banerjee, Imon , Trivedi, Hari

Mayo Clinic

European Heart Journal | February 10, 2026 | Volume: 47 | Issue: 18 | Pages: 2206-2220

10.1093/eurheartj/ehag128 | PMID 41795899 Get It

Abstract Background and Aims Women are underdiagnosed and undertreated for cardiovascular disease (CVD). Automatic quantification of breast arterial calcification (BAC) on screening mammography can identify women at risk for CVD. This study aimed to determine whether artificial intelligence–based automatic quantification of BAC from screening mammograms predicts CVD and mortality beyond PREVENT scores in a large, racially diverse, multi-institutional population. Methods This retrospective cohort study included 123 762 women from two healthcare systems who had screening mammograms. Breast arterial calcification was quantified using a transformer-based neural network for segmentation. Breast arterial calcification severity was categorized as zero (0 mm2), mild (&gt;0–10 mm2), moderate (&gt;10–25 mm2), and severe (&gt;25 mm2). Kaplan–Meier analysis, Cox proportional hazards, and Fine–Gray competing event models were used to examine the association between BAC and major adverse cardiovascular events (MACE). Results Breast arterial calcification was detected in 16.1% (internal cohort) and 20.6% (external cohort) of women and provided significant prognostic value incremental to the PREVENT score. In PREVENT adjusted models, a clear dose–response was observed. Compared with zero BAC, mild [internal: hazard ratio (HR) 1.32, 95% confidence interval (CI) 1.10–1.59; external: HR 1.28, 95% CI 1.17–1.39], moderate (internal: HR 1.75, 95% CI 1.23–2.50; external: HR 1.79, 95% CI 1.55–2.06), and severe BAC (internal: HR 3.29, 95% CI 2.15–5.05; external: HR 2.80, 95% CI 2.36–3.32) were all prognostic for any MACE. Each 1 mm2 increase in BAC conferred an additional 2%–3% risk for MACE (P &lt; .001). Conclusions Automatically quantified BAC is an independent predictor of MACE and mortality, adding prognostic value to the PREVENT score. This approach may provide an opportunistic cardiovascular risk assessment during routine mammography screening without additional radiation exposure to guide earlier and more effective preventive care for women.
Identification of a Novel Missense Homozygous Variant in LINS1 in Two Distinct Iranian Families With Consanguineous Marriage
Alimoradi, Elham, Nejati, Parham , Salmaninejad, Arash , Falsafi, Nafiseh, Molavi, Fatemeh, Alibakhshi, Mohamad Javad, Klee, E. B., Alibakhshi, Reza, Vairo, Filippo Pinto e , Alibakhshi, Reza

Mayo Clinic

Molecular Genetics & Genomic Medicine | February 9, 2026 | Volume: 14 | Issue: 2 | Pages: No page available

10.1002/mgg3.70184 | PMID 41656075 Get It

ABSTRACT Background LINS1 , the human homolog of the Drosophila segment polarity gene, encodes a key regulator of the Wingless/Wnt signaling pathway. While numerous genes have been implicated in intellectual disability (ID), only a limited number have been conclusively associated with autosomal recessive intellectual disability (ARID). Variants in LINS1 have been identified as one such cause. Methods In this study, we employed exome sequencing (ES) to investigate the genetic basis of ID in two consanguineous Iranian families. This variant was confirmed by Sanger sequencing, and segregation analysis supported its pathogenicity. Additionally, in silico analyses were conducted to explore the protein–protein interaction network of LINS1 and its functional connections to ID‐associated proteins. Results We identified a novel homozygous missense variant in LINS1 (c.1354G>C), leading to an alanine‐to‐proline substitution (p.Ala452Pro) in exon six. Conclusion Our findings provide new molecular and clinical insights into the role of LINS1 in ARID, expanding the genetic landscape of ID. This discovery has significant implications for genetic counseling and prenatal diagnosis, aiding in the identification of at‐risk couples.